| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |